Kroger Health, the arm of grocer Kroger that runs pharmacies and clinics across the U.S., said on Friday it had revamped its ...
Analyzing Madrigal Pharmaceuticals' potential in the competitive NASH drug market and why it may be right for your portfolio.
For the past year and a half, Tandra Cooper Harris and her husband, Marcus, who both have diabetes, have struggled to fill ...
Ozempic and other Type 2 diabetes medications are helping revolutionize the treatment for patients. Find out if these new ...
Learn about the side effects of Ozempic, Wegovy, Mounjaro and Zepbound, so you can weigh the risks versus benefits.
In recent months, Eli Lilly has continued to delight investors with growth in its share price. Strong sales of the company's ...
Boehringer Ingelheim today announced breakthrough results from a survodutide Phase II trial sub-analysis that demonstrate up to 64.5% of adults with fibrosis stages F2 and F3 (moderate to advanced ...
GLP-1s, like Ozempic and Wegovy, are creating a frenzy in healthcare. In just the last three months of 2022, providers wrote more than 9 million prescriptions for these drugs. While GLP-1s have ...
Our easy-to-read fact sheet provides clinicians with an overview of the mechanism of GLP-1 agonists. Our easy-to-read fact sheets provide clinicians with reliable information to share with ...
Taking a cutting-edge weight-loss drug could help extremely obese patients drop enough pounds to be eligible for bariatric surgery, a new study shows. Patients with extreme obesity -- a BMI of 70 ...
The Boston startup aims to provide an alternative obesity medicine to GLP-1 drugs, which the CEO said can come with "accessibility, cost, side effects and long-term maintenance" issues. A new ...